These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2527 related items for PubMed ID: 27556408
1. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ, COPDGene Investigators. Am J Respir Crit Care Med; 2017 Feb 01; 195(3):324-330. PubMed ID: 27556408 [Abstract] [Full Text] [Related]
7. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Martinez CH, Murray S, Barr RG, Bleecker E, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper D, Criner GJ, Curtis JL, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Krishnan JA, Lazarus SC, Leidy NK, O'Neal W, Martinez FJ, Paine R, Rennard SI, Tashkin DP, Woodruff PG, Han MK, Subpopulations and Intermediate Outcome Measures in COPD Study Investigators. Ann Am Thorac Soc; 2017 May 01; 14(5):636-642. PubMed ID: 28459622 [Abstract] [Full Text] [Related]
9. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lange P, Çolak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Lancet Respir Med; 2016 Jun 01; 4(6):454-62. PubMed ID: 27061878 [Abstract] [Full Text] [Related]
10. Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency. Hiller AM, Piitulainen E, Jehpsson L, Tanash H. Int J Chron Obstruct Pulmon Dis; 2019 Jun 01; 14():1075-1083. PubMed ID: 31213789 [Abstract] [Full Text] [Related]
11. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study. Kamada T, Kaneko M, Tomioka H. Int J Chron Obstruct Pulmon Dis; 2017 Jun 01; 12():509-516. PubMed ID: 28223791 [Abstract] [Full Text] [Related]
14. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS. Arjomandi M, Zeng S, Barjaktarevic I, Barr RG, Bleecker ER, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Cooper CB, Couper DJ, Curtis JL, Dransfield MT, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Paine R, Peters SP, Rennard SI, Woodruff PG, SPIROMICS Investigators. Eur Respir J; 2019 Oct 01; 54(4):. PubMed ID: 31439683 [Abstract] [Full Text] [Related]
15. The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline. Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JWH, Sadatsafavi M, Sin DD, Carter V, Price DB. Int J Chron Obstruct Pulmon Dis; 2020 Oct 01; 15():1909-1918. PubMed ID: 32821093 [Abstract] [Full Text] [Related]
18. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort. Perez-Padilla R, Wehrmeister FC, de Oca MM, Lopez MV, Jardim JR, Muiño A, Valdivia G, Menezes AMB. Int J Chron Obstruct Pulmon Dis; 2018 Oct 01; 13():3549-3561. PubMed ID: 30464437 [Abstract] [Full Text] [Related]